Leonard S. Jacob
Chairman at Life Science Advisors LLC
Profile
Leonard S.
Jacob was the founder of Genaera Corp.
(founded in 1989) and InKine Pharmaceutical Co., Inc. (founded in 1997), where he held the titles of Chief Operating Officer and Chairman, President & Chief Executive Officer, respectively.
He currently holds positions as Chairman at Life Science Advisors LLC, Director at QuiqMeds, Inc., Trustee at the University of the Sciences in Philadelphia, and Member-Overseers Board at Temple University School of Medicine.
His former positions include Non-Executive Chairman at Bradley Pharmaceuticals, Inc. (2006-2007), Chairman at Antares Pharma, Inc. (2008-2022), Director at Jacob Internet Fund, Inc. (1999-2010), and Vice President-World Wide at Smithkline & French Laboratories US, Inc. (1980-1989).
He also served as a Director at Colorectal Cancer Alliance.
Dr. Jacob holds a doctorate degree from both Drexel University College of Medicine and Temple University School of Medicine.
Leonard S. Jacob active positions
Companies | Position | Start |
---|---|---|
Life Science Advisors LLC | Chairman | - |
QuiqMeds, Inc.
QuiqMeds, Inc. Packaged SoftwareTechnology Services QuiqMeds, Inc. provides a cloud based enterprise platform that is intended to work across health systems and their components such as hospital emergency departments, urgent care centers, medical centers, workplace health clinics, and group practices. The company is headquartered in Malvern, PA. | Director/Board Member | - |
University of the Sciences in Philadelphia | Director/Board Member | - |
Temple University School of Medicine | Corporate Officer/Principal | - |
Former positions of Leonard S. Jacob
Companies | Position | End |
---|---|---|
ANTARES PHARMA, INC. | Chairman | 2022-05-23 |
Jacob Internet Fund, Inc. | Director/Board Member | 2009-12-31 |
Bradley Pharmaceuticals, Inc.
Bradley Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Bradley Pharmaceuticals, Inc. is a specialty pharmaceutical company, engages in the acquisition, development and marketing of prescription and products to physician specialties in the United States and international markets. The company has two divisions: Doak Dermatologics and Kenwood Therapeutics. The Doak Dermatologics division promotes branded dermatologic and podiatric products including ADOXA, KERALAC, SOLARAZE, ZODERM, LIDAMANTLE, ROSULA, SELSEB and ZONALON to dermatologists and podiatrists. The Kenwood Therapeutics division offers branded gastrointestinal products including ANAMANTLE HC, PAMINE and PAMINE FORTE to gastroenterologists, colon and rectal surgeons. It also markets nutritional supplements and respiratory products including FLORA-Q. The company’s products are used in the treatment of acne, mild to severe dry skin and nail disorders, actinic keratoses, precancerous skin lesions, topical anesthetic and anti-inflammatory diseases, dandruff, hemorrhoids and anal fissures. It markets and sells it's products through sales personnel and wholesalers. The company was founded by Daniel Glassman in 1985 and is headquartered in Fairfield, NJ. | Chairman | 2007-05-02 |
InKine Pharmaceutical Co., Inc.
InKine Pharmaceutical Co., Inc. Pharmaceuticals: MajorHealth Technology Inkine Pharmaceutical Co., Inc. develops pharmaceutical products. The firm's products include Visicol(R) and IBStat(R). Its products are used for diagnosis and treatment of gastrointestinal disorders. The company was founded by Leonard S. Jacob in 1970 and is headquartered in Blue Bell, PA. | Chief Executive Officer | 2005-10-02 |
Genaera Corp.
Genaera Corp. Pharmaceuticals: MajorHealth Technology Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA. | Founder | 1995-12-31 |
Training of Leonard S. Jacob
Drexel University College of Medicine | Doctorate Degree |
Temple University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 9 |
---|---|
Genaera Corp.
Genaera Corp. Pharmaceuticals: MajorHealth Technology Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA. | Health Technology |
Bradley Pharmaceuticals, Inc.
Bradley Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Bradley Pharmaceuticals, Inc. is a specialty pharmaceutical company, engages in the acquisition, development and marketing of prescription and products to physician specialties in the United States and international markets. The company has two divisions: Doak Dermatologics and Kenwood Therapeutics. The Doak Dermatologics division promotes branded dermatologic and podiatric products including ADOXA, KERALAC, SOLARAZE, ZODERM, LIDAMANTLE, ROSULA, SELSEB and ZONALON to dermatologists and podiatrists. The Kenwood Therapeutics division offers branded gastrointestinal products including ANAMANTLE HC, PAMINE and PAMINE FORTE to gastroenterologists, colon and rectal surgeons. It also markets nutritional supplements and respiratory products including FLORA-Q. The company’s products are used in the treatment of acne, mild to severe dry skin and nail disorders, actinic keratoses, precancerous skin lesions, topical anesthetic and anti-inflammatory diseases, dandruff, hemorrhoids and anal fissures. It markets and sells it's products through sales personnel and wholesalers. The company was founded by Daniel Glassman in 1985 and is headquartered in Fairfield, NJ. | Health Technology |
InKine Pharmaceutical Co., Inc.
InKine Pharmaceutical Co., Inc. Pharmaceuticals: MajorHealth Technology Inkine Pharmaceutical Co., Inc. develops pharmaceutical products. The firm's products include Visicol(R) and IBStat(R). Its products are used for diagnosis and treatment of gastrointestinal disorders. The company was founded by Leonard S. Jacob in 1970 and is headquartered in Blue Bell, PA. | Health Technology |
Antares Pharma, Inc.
Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. | Health Technology |
Jacob Internet Fund, Inc. | Miscellaneous |
Life Science Advisors LLC | |
Colorectal Cancer Alliance
Colorectal Cancer Alliance Miscellaneous Commercial ServicesCommercial Services Colorectal Cancer Alliance operates as non-profit organization. It provides patient support services to those affected by colon and rectal cancer. The organization was founded by Kevin Lewis in 1999 and is headquartered in Washington, DC. | Commercial Services |
Smithkline & French Laboratories US, Inc. | |
QuiqMeds, Inc.
QuiqMeds, Inc. Packaged SoftwareTechnology Services QuiqMeds, Inc. provides a cloud based enterprise platform that is intended to work across health systems and their components such as hospital emergency departments, urgent care centers, medical centers, workplace health clinics, and group practices. The company is headquartered in Malvern, PA. | Technology Services |
- Stock Market
- Insiders
- Leonard S. Jacob